The Ultimus Mask

With the recent rise of the COVID-19 pandemic, face masks and personal protective equipment (PPE) have seen a skyrocket in demands from all corners of the globe. In particular, N95 and KN95 respirators have the highest demands due to their high filtering efficiencies, providing 95% protection against viral particles, which is essential for airborne disease protection. However, their high price and limited supply that fail to meet the demand result in a shortage of safe, protective equipment for the general public. This shortfall has led to a pressing social need for affordable surgical masks with high filtering efficiency, which remains unaddressed and contributes to serious public health issues, including the potential exacerbation of thrombotic disorders. With the global strike of the Omicron variant, it seems that a revolutionary, safe product that addresses the current shortcomings in mask availability should be invented to help limit the global crisis caused by COVID-19.

Our product, the Ultimus Mask, is a surgical mask designed to provide superior airborne disease protection by completely shielding the wearer from microbial pathogens, including SARS-CoV-2, the virus responsible for COVID-19. The sterilization power of the Ultimus Mask is derived from an organic molecule that naturally occurs on our skin and within our bodies, ensuring that its toxicity level is safe for humans. The mask's filter is specially coated, allowing pathogenic particles to be trapped and sterilized as they come into contact with the walls of the passage, resulting in clean, safe air. An official evaluation conducted in a GLP-certified lab confirmed that the Ultimus Mask effectively filtered out all tested microbial pathogens, including SARS-CoV-2, completely. Additionally, its straightforward mode of action allows the production cost to be approximately 10 times lower than that of current PPE, such as N95 masks, making it a cost-effective solution for thrombotic disorders and enhancing overall public health safety.